Meperidine Hydrochloride Injection — FDA Drug Shortage

Current — Hospira, Inc., A Pfizer Company

The FDA lists a drug shortage record for Meperidine Hydrochloride Injection (injection) from Hospira, Inc., A Pfizer Company with status Current. The shortage was first posted on May 30, 2025.

Shortage details

Status
Current
Company
Hospira, Inc., A Pfizer Company
Package NDC
0409-1181-30
Dosage Form
Injection
Presentation
Demerol, Injection, 50 mg/1 mL (NDC 0409-1181-30)
Initial Posting
May 30, 2025

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.